decitabine + penpulimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for decitabine + penpulimab, covering 2022-03-04 to 2022-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade [Phase 2]